Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Spontaneous Intracerebral Hemorrhage
NCT06587737Phase 3Not yet recruiting
- Sponsor
- Population Health Research Institute
- Start
- Sep 2026
- Primary completion
- Jul 2028
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
01
Overview
A Phase 3 trial of colchicine in intracerebral hemorrhage (ICH), sponsored by Population Health Research Institute. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
colchicine
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT06587737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06587737.